mycomedtechnologies.com
STTR Award Phase 2
Information sourced from NIH Research Portfolio Online Reporting Tools (RePORT) Easy-to-use, yet sensitive, diagnostic tests for early detection of invasive aspergillosis (IA) are still-unmet medical need, as IA continues causes morbidity and death in patients with compromised immunity. In Phase I, MycoMed Technologies LLC engineered a prototype lateral flow-based device (LFD) called MycoFlow-ASP, and performance was tested